Skip to main content
. 2024 Jan 12;15:488. doi: 10.1038/s41467-023-44325-5

Table 1.

Candidate genes used in this study

Drug Abbrev. Candidate genes
Isoniazid INH katG, fabG1, inhA, ahpC, ndh, kasA, Rv1258c, Rv2752c
Ethionamide ETH ethA, ethR, fabG1, inhA, mshA, Rv3083, Rv0565c
Rifampicin RIF rpoA, rpoB, rpoC, rpoZ, Rv2752c
Rifabutin RFB rpoA, rpoB, rpoC, rpoZ, Rv2752c
Ethambutol EMB embA, embB, embC, embR, rmlD, iniA, iniC, manB, ubiA
Amikacin AMI rrs, eis, ccsA, whiB6, whiB7, aftB, fprA
Kanamycin KAN rrs, eis, ccsA, whiB6, whiB7, aftB, fprA
Levofloxacin LEV gyrA, gyrB
Moxifloxacin MXF gyrA, gyrB
Bedaquiline BDQ atpE, Rv0678, mmpL5, mmpS5, pepQ, Rv3249c
Clofazimine CFZ Rv1979c, pepQ, Rv0678, mmpL5, mmpS5, Rv3249c
Linezolid LZD rplC, rrl, Rv3249c
Delamanid DLM ddn, fgd1, fbiA, fbiB, fbiC, fbiD, Rv3249c